Our inaugural Open Meeting held on August 1st 2025 bought together almost 100 attendees,  joining both in person and online from across research, clinical, policy, and lived experience communities. The program featured presentations from OPTIMAL CRE investigators, showcasing research aligned with our three key research streams (blood cancers, myasthenia gravis and Kawasaki disease), alongside our interdisciplinary work in areas such as Ig dosing, health economics, and evidence translation. These talks highlighted the breadth of expertise within the CRE and the collaborative approaches being used to address complex challenges in immunoglobulin use.

 

We were also delighted to welcome Professor Tari Turner from Monash University, as our guest speaker. Professor Turner spoke about the development of living evidence guidelines, introducing the concept of continuously updated living guidelines that evolve as new evidence emerges. She discussed the feasibility of modular guideline development and explored potential pathways for stakeholder engagement. Her presentation highlighted the critical role of implementation science in ensuring that research findings translate into real-world clinical impact.

 

The meeting concluded with a lively panel discussion featuring both research and stakeholder representatives, sparking thoughtful dialogue on future research directions and opportunities for translation into policy and practice.

​

We sincerely thank everyone who joined us and contributed to making the inaugural OPTIMAL CRE Open Meeting such a valuable and collaborative gathering. Explore the presentations from our speakers by watching the recordings below.